HNN3.0
Register
Register
Register

Project cooperationUpdated on 21 January 2026

Vaccine Improvement - Intradermally

President at NanoPass Technologies

Nes Ziona, Israel

About

NanoPass has developed the world's smallest vaccine injection device, and registered it in Europe, USA and most major markets. We have supported and conducted >70 clinical trials showing improved immunogenicity, durability, dose sparing and improved systemic AE's across all vaccine platforms (subunit, vv, mRNA, saRNA, DNA, inactivated and attenuated vaccines). We have previously partnered in EU consortia for same and seek partners to support vaccine development, particularly for pandemics. Promising Phase 1-2 results exist for pandemic flu, COVID and many other vaccines.

Similar opportunities